The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Clinical trial NCT04007055 · TERMINATED

Trial details

NCT number: NCT04007055
Sponsor: Marissa Jarosinski
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Artery Disease Clopidogrel, Poor Metabolism of Peripheral Vascular Disease Artery Disease Peripheral Arterial Occlusive Disease

Start date: 2019-08-09
Primary completion: 2023-03-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.